The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).

The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).

Dades bibliogràfiques
Autors principals:	Kaltsas, G, Papadogias, D, Grossman, AB
Format:	Journal article
Idioma:	English
Publicat:	2004

Ítems similars

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
per: Chrisoulidou, A, et al.
Publicat: (2007)

The clinical genetics of phaeochromocytoma and paraganglioma
per: P. T. Kavinga Gunawardane, et al.

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
per: Bomanji, J, et al.
Publicat: (1993)

Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
per: Bouloux, P, et al.
Publicat: (1986)

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
per: Mukherjee, J, et al.
Publicat: (2001)

Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management
per: Foo, S.H., et al.
Publicat: (2010)

Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
per: Srirangalingam, U, et al.
Publicat: (2008)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
per: Kaltsas, G, et al.
Publicat: (2005)

Phaeochromocytoma and Paraganglioma Excision Involving the Great Vessels
per: U. Srirangalingam, et al.
Publicat: (2017-01-01)

Using parenclitic networks on phaeochromocytoma and paraganglioma tumours provides novel insights on global DNA methylation
per: Dimitria Brempou, et al.
Publicat: (2024-12-01)

Personalized diagnostics of chromaffin tumors (pheochromocytoma, paraganglioma) in oncoendocrinology
per: Pavel O. Rumyantsev, et al.
Publicat: (2018-07-01)

Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma
per: Sofia Maria Lider Burciulescu, et al.
Publicat: (2023-02-01)

A Laboratory Medicine Perspective on the Investigation of Phaeochromocytoma and Paraganglioma
per: Christopher S. Boot
Publicat: (2023-09-01)

Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
per: Srirangalingam, U, et al.
Publicat: (2009)

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
per: Kaltsas, G, et al.
Publicat: (2004)

Phaeochromocytoma crisis presenting with profound hypoglycaemia and subsequent hypertension.
per: Frankton, S, et al.
Publicat: (2009)

Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
per: Astuti, D, et al.
Publicat: (2003)

Predictors of outcome in phaeochromocytomas and paragangliomas [version 1; referees: 3 approved]
per: Marlo Nicolas, et al.
Publicat: (2017-12-01)

A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
per: Prodromos Chatzikyriakou, et al.
Publicat: (2023-12-01)

Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
per: Druce, MR, et al.
Publicat: (2009)

The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma
per: Samsudin, Intan Nureslyna, et al.
Publicat: (2018)

Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis
per: Andrea Luchetti, et al.
Publicat: (2015-01-01)

Genetic testing and immunohistochemistry for SDHB in phaeochromocytoma-paraganglioma syndromes: the South Australian experience
per: Poplawski NK, et al.
Publicat: (2012-04-01)

The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma.
per: Sheaves, R, et al.
Publicat: (1995)

Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.
per: Nölting, S, et al.
Publicat: (2012)

The use of temozolomide in paediatric metastatic phaeochromocytoma/paraganglioma: A case report and literature review
per: Calum Urquhart, et al.
Publicat: (2022-11-01)

Unilateral Sporadic Carotid Paraganglioma
per: Sushil G. Kachewar, et al.
Publicat: (2011-12-01)

Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.
per: Dahia, P, et al.
Publicat: (1997)

Rare presentation of collapse and cardiomyopathy in phaeochromocytoma
per: Rajiv Singh, et al.
Publicat: (2021-05-01)

Malignant pituitary tumours.
per: Kaltsas, G, et al.
Publicat: (1998)

Phaeochromocytoma Crisis: Two Cases of Undiagnosed Phaeochromocytoma Presenting after Elective Nonrelated Surgical Procedures
per: P. C. Johnston, et al.
Publicat: (2013-01-01)

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma
per: Wong Nora, et al.
Publicat: (2006-01-01)

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
per: Nastos, K, et al.
Publicat: (2017)

Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
per: Lawrence, J, et al.
Publicat: (2004)

Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
per: Kaltsas, G, et al.
Publicat: (2002)

Intracerebral haemorrhage: A rare presentation of phaeochromocytoma
per: Swati Chhikara, et al.
Publicat: (2021-01-01)

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
per: Kaltsas, G, et al.
Publicat: (2003)

A Rare Case: Sporadic Bladder Paraganglioma
per: Hakan Ercil, et al.
Publicat: (2013-08-01)

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior
per: David J. Pinato, et al.
Publicat: (2017-11-01)

MIBG scans for phaeochromocytoma: time to abandon the technique?
per: Grossman, A, et al.
Publicat: (2009)